DiaSorin SpA
MIL:DIA
DiaSorin SpA
Non-Reccuring Items
DiaSorin SpA
Non-Reccuring Items Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Non-Reccuring Items | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
DiaSorin SpA
MIL:DIA
|
Non-Reccuring Items
-€6.7m
|
CAGR 3-Years
33%
|
CAGR 5-Years
-8%
|
CAGR 10-Years
N/A
|
|
|
El En SpA
MIL:ELN
|
Non-Reccuring Items
€162.7k
|
CAGR 3-Years
-1%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
N/A
|
|
DiaSorin SpA
Glance View
In the heart of the global healthcare landscape, DiaSorin SpA stands as a testament to innovation and precision in the field of biotechnology. Founded in 1968 in Italy, the company built its reputation on developing and producing diagnostic tests that help identify and monitor diseases. With a primary focus on immunodiagnostic and molecular diagnostic products, DiaSorin excels in creating high-quality, reliable solutions that clinicians and labs around the world depend on. Their product portfolio ranges widely, covering infectious diseases, oncology, endocrinology, and more. By leveraging cutting-edge research and development processes, DiaSorin not only prioritizes accuracy and efficiency in its testing solutions but also adapts to the ever-evolving demands of the medical world, cementing its role as a leader in diagnostic innovation. From a business perspective, DiaSorin's revenue streams are deeply intertwined with its prowess in developing proprietary testing technologies, including both instruments and consumables. The company operates with a dual-channel business model where it sells diagnostic machines to laboratories, hospitals, and clinics while simultaneously providing the reagents and kits necessary for these machines' continuous operation. This approach ensures not only a sale of sophisticated equipment but also a recurring revenue stream from the consumables needed for diagnostics. With a strategic emphasis on research and partnerships, DiaSorin has expanded its reach globally, ensuring its products meet diverse regional healthcare requirements. Through a combination of robust product offerings and strategic global expansion, DiaSorin continues to thrive and maintain its position as a pivotal contributor to the field of diagnostic medicine.
See Also
What is DiaSorin SpA's Non-Reccuring Items?
Non-Reccuring Items
-6.7m
EUR
Based on the financial report for Dec 31, 2024, DiaSorin SpA's Non-Reccuring Items amounts to -6.7m EUR.
What is DiaSorin SpA's Non-Reccuring Items growth rate?
Non-Reccuring Items CAGR 5Y
-8%
Over the last year, the Non-Reccuring Items growth was 69%. The average annual Non-Reccuring Items growth rates for DiaSorin SpA have been 33% over the past three years , -8% over the past five years .
You don't have any saved screeners yet